Share-based Payment Arrangement, Noncash Expense of bluebird bio, Inc. from 31 Dec 2011 to 31 Mar 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of noncash expense for share-based payment arrangement.
- Summary
-
bluebird bio, Inc. quarterly and annual Share-based Payment Arrangement, Noncash Expense in USD history and change rate from 31 Dec 2011 to 31 Mar 2025.
- bluebird bio, Inc. Share-based Payment Arrangement, Noncash Expense for the quarter ending 31 Mar 2025 was $1,660,000, a 56% decline year-over-year.
- bluebird bio, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2024 was $13,737,000, a 29% decline from 2023.
- bluebird bio, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2023 was $19,429,000, a 45% decline from 2022.
- bluebird bio, Inc. annual Share-based Payment Arrangement, Noncash Expense for 2022 was $35,090,000, a 73% decline from 2021.
- Source SEC data
- View on sec.gov
Share-based Payment Arrangement, Noncash Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Noncash Expense, Quarterly (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Noncash Expense, Annual (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Annual Change (%)
bluebird bio, Inc. Quarterly Share-based Payment Arrangement, Noncash Expense (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2025 | $1,660,000 | -$2,101,000 | -56% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 14 May 2025 | 2025 | Q1 | |
| Q1 2024 | $3,761,000 | -$1,630,000 | -30% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 14 May 2025 | 2025 | Q1 | |
| Q1 2023 | $5,391,000 | -$6,999,000 | -56% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 13 Sep 2024 | 2024 | Q1 | |
| Q1 2022 | $12,390,000 | -$30,137,000 | -71% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 09 May 2023 | 2023 | Q1 | |
| Q1 2021 | $42,527,000 | +$6,234,000 | +17% | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 09 May 2022 | 2022 | Q1 | |
| Q1 2020 | $36,293,000 | +$3,952,000 | +12% | 01 Jan 2020 | 31 Mar 2020 | 10-Q | 05 May 2021 | 2021 | Q1 | |
| Q1 2019 | $32,341,000 | +$9,346,000 | +41% | 01 Jan 2019 | 31 Mar 2019 | 10-Q | 11 May 2020 | 2020 | Q1 | |
| Q1 2018 | $22,995,000 | +$11,514,000 | +100% | 01 Jan 2018 | 31 Mar 2018 | 10-Q | 03 May 2019 | 2019 | Q1 | |
| Q1 2017 | $11,481,000 | +$1,338,000 | +13% | 01 Jan 2017 | 31 Mar 2017 | 10-Q | 02 May 2018 | 2018 | Q1 | |
| Q1 2016 | $10,143,000 | +$4,711,000 | +87% | 01 Jan 2016 | 31 Mar 2016 | 10-Q | 03 May 2017 | 2017 | Q1 | |
| Q1 2015 | $13,702,000 | $5,432,000 | +$2,939,000 | +118% | 01 Jan 2015 | 31 Mar 2015 | 10-Q | 04 May 2016 | 2016 | Q1 |
| Q4 2014 | $10,763,000 | $3,005,000 | +$1,348,000 | +81% | 01 Oct 2014 | 31 Dec 2014 | 10-K | 22 Feb 2017 | 2016 | FY |
| Q3 2014 | $9,415,000 | $2,914,000 | +$398,000 | +16% | 01 Jul 2014 | 30 Sep 2014 | 10-Q | 12 Nov 2014 | 2014 | Q3 |
| Q2 2014 | $9,017,000 | $2,351,000 | +$694,000 | +42% | 01 Apr 2014 | 30 Jun 2014 | 10-Q | 12 Aug 2014 | 2014 | Q2 |
| Q1 2014 | $8,323,000 | $2,493,000 | +$1,832,000 | +277% | 01 Jan 2014 | 31 Mar 2014 | 10-Q | 06 May 2015 | 2015 | Q1 |
| Q4 2013 | $6,491,000 | $1,657,000 | 01 Oct 2013 | 31 Dec 2013 | 10-K | 25 Feb 2016 | 2015 | FY | ||
| Q3 2013 | $2,516,000 | +$2,331,000 | +1260% | 01 Jul 2013 | 30 Sep 2013 | 10-Q | 12 Nov 2014 | 2014 | Q3 | |
| Q2 2013 | $1,657,000 | +$1,505,000 | +990% | 01 Apr 2013 | 30 Jun 2013 | 10-Q | 12 Aug 2014 | 2014 | Q2 | |
| Q1 2013 | $661,000 | 01 Jan 2013 | 31 Mar 2013 | 10-Q | 13 May 2014 | 2014 | Q1 | |||
| Q3 2012 | $185,000 | 01 Jul 2012 | 30 Sep 2012 | 10-Q | 14 Nov 2013 | 2013 | Q3 | |||
| Q2 2012 | $152,000 | 01 Apr 2012 | 30 Jun 2012 | 10-Q | 14 Aug 2013 | 2013 | Q2 |
bluebird bio, Inc. Annual Share-based Payment Arrangement, Noncash Expense (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2024 | $13,737,000 | -$5,692,000 | -29% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 27 Mar 2025 | 2024 | FY |
| 2023 | $19,429,000 | -$15,661,000 | -45% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 27 Mar 2025 | 2024 | FY |
| 2022 | $35,090,000 | -$92,825,000 | -73% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 13 Sep 2024 | 2023 | FY |
| 2021 | $127,915,000 | -$28,716,000 | -18% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 29 Mar 2023 | 2022 | FY |
| 2020 | $156,631,000 | -$3,998,000 | -2.5% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 29 Mar 2023 | 2022 | FY |
| 2019 | $160,629,000 | +$49,793,000 | +45% | 01 Jan 2019 | 31 Dec 2019 | 10-K | 04 Mar 2022 | 2021 | FY |
| 2018 | $110,836,000 | +$57,554,000 | +108% | 01 Jan 2018 | 31 Dec 2018 | 10-K | 23 Feb 2021 | 2020 | FY |
| 2017 | $53,282,000 | +$13,526,000 | +34% | 01 Jan 2017 | 31 Dec 2017 | 10-K | 18 Feb 2020 | 2019 | FY |
| 2016 | $39,756,000 | -$1,364,000 | -3.3% | 01 Jan 2016 | 31 Dec 2016 | 10-K | 21 Feb 2019 | 2018 | FY |
| 2015 | $41,120,000 | +$30,357,000 | +282% | 01 Jan 2015 | 31 Dec 2015 | 10-K | 21 Feb 2018 | 2017 | FY |
| 2014 | $10,763,000 | +$4,272,000 | +66% | 01 Jan 2014 | 31 Dec 2014 | 10-K | 22 Feb 2017 | 2016 | FY |
| 2013 | $6,491,000 | +$5,669,000 | +690% | 01 Jan 2013 | 31 Dec 2013 | 10-K | 25 Feb 2016 | 2015 | FY |
| 2012 | $822,000 | -$41,000 | -4.8% | 01 Jan 2012 | 31 Dec 2012 | 10-K | 25 Feb 2015 | 2014 | FY |
| 2011 | $863,000 | 01 Jan 2011 | 31 Dec 2011 | 10-K | 05 Mar 2014 | 2013 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.